By Buy This GLP Editorial Team · Editorial profile: Neil Sanders
SurpassMD review
Intro versus renewal
SurpassMD separates the first subscription price from the recurring rate for each supply term.
What SurpassMD charges, and what it bills
Each row shows one medication and delivery route. Where two prices appear, the published figure comes from the provider. The monthly estimate is adjusted for the billing interval or required charges described below.
| Product | Price | 6-month estimate | As the dose rises |
|---|---|---|---|
| Semaglutide, injectionDose pricing for this offer is unconfirmed. | Published$114Monthly estimate$219 | $1,314 | Dose pricing for this offer is unconfirmed. |
| Tirzepatide, injectionDose pricing for this offer is unconfirmed. | Published$177Monthly estimate$309 | $1,854 | Dose pricing for this offer is unconfirmed. |
- Semaglutide, injection: The $114 headline is the introductory price on the twelve-month supply; the same table prices a 30-day supply at $219 at the standard renewal rate, with $175 introductory, and the footnote makes the introductory column a discount-code price on the first subscription. Six months at the monthly estimate comes to $1,314, compared with $684, a difference of $630.
- Tirzepatide, injection: The $177 headline is the introductory twelve-month rung; the 30-day row of the same table is $309 at the standard renewal rate and $247 introductory. Six months at the monthly estimate comes to $1,854, compared with $1,062, a difference of $792.
The 6-month estimate applies the monthly equivalent for every month. If your plan offers an introductory price, use the actual first charge and the renewal price to calculate your total. Check when any upfront charges are due. Your total may change with your dose, lab work or shipping. See the plan details below for charges SurpassMD publishes separately.
The bottom line
The lowest displayed rates pair introductory codes with a twelve-month supply. Compare the 30-day renewal row if you want a shorter commitment.
Disclosure: Buy This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.
Pricing transparency
How SurpassMD publishes its prices
On the 30-day plans, the standard renewal rate is $219 for semaglutide and $309 for tirzepatide. With an eligible code, the first-subscription figures are $175 and $247. Longer terms have their own rates.
At a glance
- Category
- GLP-1 sellers by price
- Molecule
- Semaglutide · Tirzepatide
- Form
- Injection
- States
- 51
- From
- $219/mo
The seller
What SurpassMD is
SurpassMD is an online platform that connects patients to independent clinicians and outside dispensing pharmacies. Its public catalog includes compounded injections and an oral semaglutide option.
How it works
A clinician reviews medical history, goals and current medicines. If treatment is prescribed, a pharmacy prepares and ships the medication.
Branded or compounded
The main injectable pricing tables cover compounded semaglutide and tirzepatide. The oral option appears in the general catalog, separate from those injectable rates.
Where the money holds, and where it moves
Predictable
- Drug pages display introductory and renewal pricing side by side.
Moves, or is not stated
- The lowest advertised figures require the longest term and a qualifying code.
Who this is worth it for
People who want a published renewal table before choosing a supply term
Who should price elsewhere
People who want insurance billed for their treatment
The molecules
What SurpassMD prescribes, and the evidence for it
These studies examine the medicines, not this provider. Results with approved products do not establish the quality or effectiveness of a seller’s compounded formulation.
- Oral Semaglutide vs Injection: Wegovy Doses and Trial Results
In the US, Wegovy tablet maintenance is 25 mg daily. The usual recommended injection dose is 2.4 mg weekly for adults managing weight.
- Is Tirzepatide Worth the Extra Cost Over Semaglutide?
Average weight loss was 20.2% with tirzepatide and 13.7% with semaglutide in a head-to-head trial. A separate observational study found an uncertain difference in cardiovascular outcomes.
Priced against
Sellers to price beside SurpassMD
MyFastRxPeople who want to compare a stated renewal price with the first payment
See MyFastRx →
Mint MedPeople who can confirm which public offer applies to them.
See Mint Med →
Ozari HealthPeople comparing the full price and eligibility of monthly and quarterly offers.
See Ozari Health →
More GLP-1 sellers by price priced end to end: Medsol RXMEDViMetaboost RxMevo HealthMidi HealthMint Medical Clinic
Sponsored alternative
SkinnyRx
Buyers choosing tirzepatide who want its standing rate before an intake
Check SkinnyRx availability →Frequently asked
Is shipping separate from the quoted subscription?
How does SurpassMD compare with other GLP-1 sellers by price on price?
Provider information
Plans and terms behind the assessment
Checked . Confirm current terms before paying.
Or go back to the price desk and compare SurpassMD against every seller on it.